Previous Close | 0.1750 |
Open | 0.1750 |
Bid | 0.1700 x N/A |
Ask | 0.1750 x N/A |
Day's Range | 0.1700 - 0.1750 |
52 Week Range | 0.1700 - 0.5400 |
Volume | |
Avg. Volume | 137,880 |
Market Cap | 51.287M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.5200 |
Earnings Date | Aug 21, 2023 - Aug 25, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 0.50 |
Q1 2023 revenue of $26.1 million compared to $25.9 million in Q4 2022Q1 2023 gross profit margin1 of 36.1%, 130 bps improvement from the previous quarterQ1 2023 Adjusted EBITDA2 loss of $1.6 million, $0.9 million improvement from the previous quarter. Net loss of $7.1 million in Q1 2023.Cash and cash equivalents of $18.8 million at the end of Q1 2023Multi year contract signings of $2.9 million in annual recurring revenue in Q1 2023 VANCOUVER, British Columbia, May 29, 2023 (GLOBE NEWSWIRE) -- Cl
Will release its financial results for the first quarter of 2023 on Monday, May 29, after market close. ...
VANCOUVER, British Columbia, May 24, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company transforming the delivery of care, is pleased to announce that the Company will release its financial results for the first quarter of 2023 on Monday, May 29, 2023, after market close. CloudMD will hold its Q1 2023 earnings conference call and webinar on Tuesday, May 30, 2023, at 9:30 am ET (6:
VANCOUVER, British Columbia, May 11, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (“CloudMD”), an innovative health services company transforming the delivery of care, and XTM Inc. (“XTM”) (QB: XTMIF / CSE:PAID / FSE:7XT), a Fintech creator of disruptive payment innovations and staff management solutions to inspire today's workers in the hospitality, personal care and service space, today announced an innovative partnership to bring Employee
Full year 2022 revenue of $114.5 million compared to $70.1 million in 2021Q4 2022 revenue of $25.9 million compared to $28.1 million in Q4 2021Q4 2022 gross profit margin of 34.8%, 30bps improvement from the previous quarterQ4 2022 Adjusted EBITDA1 loss of $2.6 million, $0.5 million improvement from the previous quarter. Net loss of $13.0 million in Q4 2022.Cash and cash equivalents of $24.1 million at the end of 2022Multi-year contract signings of $12.2 million in annual recurring revenue in 20
VANCOUVER, British Columbia, April 13, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company transforming the delivery of care, is pleased to announce that the Company will release its financial results for the fourth quarter of 2022 on Monday, April 24, 2023, after market close. CloudMD will hold its Q4 2022 earnings conference call and webinar on Tuesday, April 25, 2023, at 9:30 am
VANCOUVER, British Columbia, April 12, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company transforming the delivery of care, is pleased to announce that it has expanded its partnership with Benefits Alliance to cover all Kii services including EFAP, iCBT, Mental Health Coaching, Medical Second Opinion and Telemedicine. The expanded partnership allows over 8,000 employee benefit pl
CloudMD strengthens its commitment to innovation, exceptional customer experiences, data-driven insights, security, and complianceVANCOUVER, British Columbia, April 10, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company transforming the delivery of care, announced the appointment of Dhruv Chandra as the Company’s new Chief Technology Officer. Dhruv will oversee and provide strateg
VANCOUVER, British Columbia, April 04, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company transforming the delivery of care, is pleased to announce a new vendor of record agreement for Employee & Family Assistance Program (“EFAP”), Internet based Cognitive Therapy (“iCBT”), Mental Health Coach, and Nurse Navigation Services provided through Kii. The non-exclusive agreement is with
VANCOUVER, British Columbia, April 03, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health solutions company transforming the delivery of care, announced the launch of online prescription renewals through VisionPros. As of March 31st, 2023, individuals in qualifying U.S. states can renew their vision care prescriptions conveniently online. The inclusion of online prescription renewal is consistent
Under his leadership, CloudMD will continue to focus on empowering healthier lives through healthcare navigation, a robust clinical network and technology enhanced outcome-focused servicesVANCOUVER, British Columbia, March 27, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health solutions company transforming the delivery of care, announced the appointment of Bram Lowsky as Executive Vice President,
VANCOUVER, British Columbia, March 14, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company transforming the delivery of care, is pleased to announce that Karen Adams, CEO, will be participating in the KeyBanc Capital Markets Life Sciences & MedTech Virtual Investor Forum on March 22, 2023. Karen Adams will be participating in a fire side chat with KeyBanc analyst Scott Schoenhaus a
The study conducted by ANDx Research Group shows that employee’s want more choice, better communication, and support with navigating options and coverage Unlocking the Potential of Employer-Provided Health Benefits Unlocking the Potential of Employer-Provided Health Benefits VANCOUVER, British Columbia, March 01, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company transforming the
VANCOUVER, British Columbia, Feb. 13, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company transforming the delivery of care, is pleased to announce the launch of its Spanish language therapist-assisted internet-based Cognitive Behavioural Therapy (“TAiCBT”) as part of its mental health offering in the United States. English and Spanish EAP and TAiCBT are delivered through CloudMD’s
VANCOUVER, British Columbia, Dec. 19, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology and innovative health services company transforming the delivery of care, is pleased to announce that it has closed the previously announced divestiture of its British Columbia based pharmacies to Neighbourly Pharmacy Inc. (TSX:NBLY) (“Neighbourly”) for approximately $3.8 million. The closing of this transa
VANCOUVER, British Columbia, Dec. 15, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology and innovative health services company transforming the delivery of care, is pleased to announce the approval of each item of business considered at CloudMD’s Annual and Special Meeting of Shareholders held on December 15, 2022, set out in more detail below. Election of Directors Shareholders approved setti
VANCOUVER, British Columbia, Nov. 21, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology and innovative health services company transforming the delivery of care, is pleased to announce that it will be filing its management information circular and related voting materials (the “Meeting Materials”) for the annual and special meeting of shareholders (the “Meeting”) with Canadian regulators today
VANCOUVER, British Columbia, Nov. 18, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology and innovative health services company transforming the delivery of care, is pleased to announce that the Company has been invited to participate in the TD Securities Technology Conference taking place in Toronto from Monday, November 21st to Wednesday, November 23rd. Senior members of management will be pa
Q3 2022 revenue from continuing operations of $27.5 million, which does not include revenue from its Clinics & Pharmacies Division or Cloud Practice which are classified as discontinuing operations. Q3 2022 gross margin of 34.5% compared to 31% in Q2 2022, reflective of the higher margins of CloudMD’s continuing operations.Q3 2022 Adjusted EBITDA loss of $3.0 million.Cash and cash equivalents were $27.5 million at the end of the quarter which does not include proceeds from divestitures announced
VANCOUVER, British Columbia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (“CloudMD” or the “Company”), a healthcare technology and innovative health services company transforming the delivery of care, announced today that the Company will release its financial results for the third quarter of 2022 on Monday, November 14, 2022 after market close. CloudMD will hold its Q3 2022 earnings conference call and webinar on Tuesday, November
VANCOUVER, British Columbia, Nov. 02, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology and innovative health services company transforming the delivery of care, is pleased to announce that it has closed the previously announced divestiture of its primary care clinics and Cloud Practice to Well Health Technologies Corp. (TSX:WELL, OTCQX: WHTCF) (“WELL”) for approximately $5.75 million in cash.
VANCOUVER, British Columbia, Oct. 31, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology and innovative health services company transforming the delivery of care, is pleased to announce that it has entered into a definitive agreement (the “Agreement”) with Neighbourly Pharmacy Inc. (TSX:NBLY) (“Neighbourly”) for the sale of its British Columbia based pharmacies for approximately $3.8 million. N
VANCOUVER, British Columbia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology and innovative health services company transforming the delivery of care, is pleased to announce that it has entered into a definitive agreement with Well Health Technologies Corp. (TSX:WELL, OTCQX: WHTCF) (“WELL”) for the sale of its British Columbia based primary care clinics and Cloud Practice, its cloud
Recent research study demonstrates that the majority of clients experience reliable improvement in symptoms after just two months of treatmentVANCOUVER, British Columbia, Sept. 15, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology and innovative health services company transforming the delivery of care, today released a research study that demonstrates the positive outcome results from using i
Q2 2022 revenue of $40.3 million, an increase of 157% over the same period in 2021.Q2 2022 gross margin of 31.0%1 compared to 35.5% in Q2 2021.Q2 2022 Adjusted EBITDA2 loss of $3.2 million compared to a loss of $0.6 million in Q2 2021. Net loss of $44.2 million during Q2 2022 driven by $33.0 million non-cash impairment charge, compared to loss of $6.6 million in Q2 2021.Strategic priorities include driving organic growth, further cost optimization and financial stability and prudent cash managem